D
Immutep Limited
PRRUF
$0.20
-$0.004-1.96%
D
Sell
2/6/2025Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 2/6/2025 due to an increase in the volatility index and growth index.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 2/6/2025 due to an increase in the volatility index and growth index.
E
Sell
1/22/2025Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 1/22/2025 due to a decline in the volatility index.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 1/22/2025 due to a decline in the volatility index.
D
Sell
1/7/2025Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 1/7/2025 due to an increase in the volatility index.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 1/7/2025 due to an increase in the volatility index.
E
Sell
12/20/2024Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 12/20/2024 due to a decline in the volatility index and growth index.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 12/20/2024 due to a decline in the volatility index and growth index.
D
Sell
10/11/2024Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 10/11/2024 due to an increase in the total return index and volatility index.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 10/11/2024 due to an increase in the total return index and volatility index.
E
Sell
9/24/2024Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 9/24/2024 due to a decline in the volatility index.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 9/24/2024 due to a decline in the volatility index.
D
Sell
9/6/2024Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 9/6/2024 due to an increase in the growth index, solvency index and volatility index. Total revenue increased 0.21% from $569.2 to $570.4.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 9/6/2024 due to an increase in the growth index, solvency index and volatility index. Total revenue increased 0.21% from $569.2 to $570.4.
E
Sell
9/3/2024Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 9/3/2024 due to a decline in the valuation index and solvency index.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 9/3/2024 due to a decline in the valuation index and solvency index.
D
Sell
12/6/2023Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 12/6/2023 due to an increase in the volatility index.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 12/6/2023 due to an increase in the volatility index.
E
Sell
11/20/2023Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 11/20/2023 due to a decline in the growth index, volatility index and total return index.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 11/20/2023 due to a decline in the growth index, volatility index and total return index.
D
Sell
10/31/2023Upgraded
Immutep Limited (PRRUF) was upgraded to D- from E+ on 10/31/2023 due to an increase in the volatility index.
Immutep Limited (PRRUF) was upgraded to D- from E+ on 10/31/2023 due to an increase in the volatility index.
E
Sell
10/16/2023Downgrade
Immutep Limited (PRRUF) was downgraded to E+ from D- on 10/16/2023 due to a noticeable decline in the growth index and volatility index. Total revenue declined 2.27% from $622 to $607.9.
Immutep Limited (PRRUF) was downgraded to E+ from D- on 10/16/2023 due to a noticeable decline in the growth index and volatility index. Total revenue declined 2.27% from $622 to $607.9.
D
Sell
3/14/2023Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the growth index, solvency index and total return index. Total revenue declined 3.83% from $725.3 to $697.5.
Immutep Limited (PRRUF) was downgraded to D- from D on 3/14/2023 due to a noticeable decline in the growth index, solvency index and total return index. Total revenue declined 3.83% from $725.3 to $697.5.
D
Sell
2/23/2023Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
Immutep Limited (PRRUF) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
Immutep Limited (PRRUF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
1/4/2023Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 1/4/2023 due to a decline in the total return index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 1/4/2023 due to a decline in the total return index.
D
Sell
12/14/2022Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 12/14/2022 due to an increase in the total return index, volatility index and solvency index.
Immutep Limited (PRRUF) was upgraded to D+ from D on 12/14/2022 due to an increase in the total return index, volatility index and solvency index.
D
Sell
11/18/2022Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 11/18/2022 due to a decline in the total return index, volatility index and valuation index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 11/18/2022 due to a decline in the total return index, volatility index and valuation index.
D
Sell
11/3/2022Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 11/3/2022 due to an increase in the volatility index.
Immutep Limited (PRRUF) was upgraded to D+ from D on 11/3/2022 due to an increase in the volatility index.
D
Sell
10/19/2022Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 10/19/2022 due to a decline in the volatility index and total return index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 10/19/2022 due to a decline in the volatility index and total return index.
D
Sell
10/4/2022Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 10/4/2022 due to an increase in the volatility index and valuation index.
Immutep Limited (PRRUF) was upgraded to D+ from D on 10/4/2022 due to an increase in the volatility index and valuation index.
D
Sell
9/19/2022Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 9/19/2022 due to a decline in the volatility index and total return index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 9/19/2022 due to a decline in the volatility index and total return index.
D
Sell
9/1/2022Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 9/1/2022 due to an increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.0067 to -$0.0066, operating cash flow increased 1.33% from -$6.68M to -$6.59M, and EBIT increased 1.33% from -$6.16M to -$6.07M.
Immutep Limited (PRRUF) was upgraded to D+ from D on 9/1/2022 due to an increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.0067 to -$0.0066, operating cash flow increased 1.33% from -$6.68M to -$6.59M, and EBIT increased 1.33% from -$6.16M to -$6.07M.
D
Sell
5/5/2022Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 5/5/2022 due to an increase in the growth index and total return index.
Immutep Limited (PRRUF) was upgraded to D from D- on 5/5/2022 due to an increase in the growth index and total return index.
D
Sell
4/20/2022Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
Immutep Limited (PRRUF) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
11/23/2021Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Immutep Limited (PRRUF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the growth index and valuation index. Total revenue declined 0.36% from $637.7 to $635.4.
Immutep Limited (PRRUF) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the growth index and valuation index. Total revenue declined 0.36% from $637.7 to $635.4.
D
Sell
7/24/2020Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 7/24/2020 due to a decline in the total return index and volatility index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 7/24/2020 due to a decline in the total return index and volatility index.
D
Sell
7/9/2020Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 7/9/2020 due to an increase in the total return index and volatility index.
Immutep Limited (PRRUF) was upgraded to D+ from D on 7/9/2020 due to an increase in the total return index and volatility index.
D
Sell
6/18/2020Downgrade
Immutep Limited (PRRUF) was downgraded to D from D+ on 6/18/2020 due to a major decline in the total return index and volatility index.
Immutep Limited (PRRUF) was downgraded to D from D+ on 6/18/2020 due to a major decline in the total return index and volatility index.
D
Sell
5/1/2020Upgraded
Immutep Limited (PRRUF) was upgraded to D+ from D on 5/1/2020 due to an increase in the valuation index and solvency index.
Immutep Limited (PRRUF) was upgraded to D+ from D on 5/1/2020 due to an increase in the valuation index and solvency index.
D
Sell
2/21/2020Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 2/21/2020 due to an increase in the efficiency index, solvency index and total return index. Total capital increased 4.17% from $24.63M to $25.65M, debt to equity declined from 0.3 to 0.29, and net income increased 0.3% from -$2.04M to -$2.03M.
Immutep Limited (PRRUF) was upgraded to D from D- on 2/21/2020 due to an increase in the efficiency index, solvency index and total return index. Total capital increased 4.17% from $24.63M to $25.65M, debt to equity declined from 0.3 to 0.29, and net income increased 0.3% from -$2.04M to -$2.03M.
D
Sell
2/18/2020Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 2/18/2020 due to a decline in the valuation index, growth index and volatility index.
Immutep Limited (PRRUF) was downgraded to D- from D on 2/18/2020 due to a decline in the valuation index, growth index and volatility index.
D
Sell
11/19/2019Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 11/19/2019 due to an increase in the volatility index, growth index and total return index.
Immutep Limited (PRRUF) was upgraded to D from D- on 11/19/2019 due to an increase in the volatility index, growth index and total return index.
D
Sell
10/1/2019Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 10/1/2019 due to a decline in the volatility index.
Immutep Limited (PRRUF) was downgraded to D- from D on 10/1/2019 due to a decline in the volatility index.
D
Sell
9/16/2019Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 9/16/2019 due to an increase in the volatility index and total return index.
Immutep Limited (PRRUF) was upgraded to D from D- on 9/16/2019 due to an increase in the volatility index and total return index.
D
Sell
8/21/2019Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 8/21/2019 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 1.23% from $22.74M to $22.46M.
Immutep Limited (PRRUF) was downgraded to D- from D on 8/21/2019 due to a decline in the efficiency index, solvency index and volatility index. Total capital declined 1.23% from $22.74M to $22.46M.
D
Sell
4/15/2019Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 4/15/2019 due to an increase in the volatility index and total return index.
Immutep Limited (PRRUF) was upgraded to D from D- on 4/15/2019 due to an increase in the volatility index and total return index.
D
Sell
3/29/2019Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 3/29/2019 due to a decline in the total return index and growth index.
Immutep Limited (PRRUF) was downgraded to D- from D on 3/29/2019 due to a decline in the total return index and growth index.
D
Sell
2/28/2019Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 2/28/2019 due to an increase in the efficiency index and valuation index. Net income increased 1.96% from -$3.17M to -$3.11M.
Immutep Limited (PRRUF) was upgraded to D from D- on 2/28/2019 due to an increase in the efficiency index and valuation index. Net income increased 1.96% from -$3.17M to -$3.11M.
D
Sell
11/14/2018Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 11/14/2018 due to a decline in the volatility index and total return index.
Immutep Limited (PRRUF) was downgraded to D- from D on 11/14/2018 due to a decline in the volatility index and total return index.
D
Sell
10/25/2018Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 10/25/2018 due to an increase in the total return index and volatility index.
Immutep Limited (PRRUF) was upgraded to D from D- on 10/25/2018 due to an increase in the total return index and volatility index.
D
Sell
10/4/2018Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 10/4/2018 due to a decline in the volatility index.
Immutep Limited (PRRUF) was downgraded to D- from D on 10/4/2018 due to a decline in the volatility index.
D
Sell
9/19/2018Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 9/19/2018 due to an increase in the total return index and volatility index.
Immutep Limited (PRRUF) was upgraded to D from D- on 9/19/2018 due to an increase in the total return index and volatility index.
D
Sell
8/22/2018Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 8/22/2018 due to a noticeable decline in the total return index and efficiency index. Total capital declined 3.81% from $30.89M to $29.71M.
Immutep Limited (PRRUF) was downgraded to D- from D on 8/22/2018 due to a noticeable decline in the total return index and efficiency index. Total capital declined 3.81% from $30.89M to $29.71M.
D
Sell
5/14/2018Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 5/14/2018 due to a noticeable increase in the total return index and valuation index.
Immutep Limited (PRRUF) was upgraded to D from D- on 5/14/2018 due to a noticeable increase in the total return index and valuation index.
D
Sell
4/2/2018Downgrade
Immutep Limited (PRRUF) was downgraded to D- from D on 4/2/2018 due to a decline in the valuation index.
Immutep Limited (PRRUF) was downgraded to D- from D on 4/2/2018 due to a decline in the valuation index.
D
Sell
3/15/2018Upgraded
Immutep Limited (PRRUF) was upgraded to D from D- on 3/15/2018 due to an increase in the volatility index, total return index and valuation index.
Immutep Limited (PRRUF) was upgraded to D from D- on 3/15/2018 due to an increase in the volatility index, total return index and valuation index.
D
Sell
11/9/2017Downgrade
Prima BioMed Ltd (PRRUF) was downgraded to D- from D on 11/9/2017 due to a decline in the volatility index and valuation index.
Prima BioMed Ltd (PRRUF) was downgraded to D- from D on 11/9/2017 due to a decline in the volatility index and valuation index.
D
Sell
10/25/2017Upgraded
Prima BioMed Ltd (PRRUF) was upgraded to D from D- on 10/25/2017 due to an increase in the volatility index and total return index.
Prima BioMed Ltd (PRRUF) was upgraded to D from D- on 10/25/2017 due to an increase in the volatility index and total return index.
D
Sell
9/20/2017Downgrade
Prima Biomed Ltd. (PRRUF) was downgraded to D- from D on 9/20/2017 due to a decline in the total return index, growth index and solvency index. EBIT declined 98.62% from -$1.35M to -$2.68M, the quick ratio declined from 12.91 to 5.48, and total revenue declined 52.42% from $1.29M to $615.9.
Prima Biomed Ltd. (PRRUF) was downgraded to D- from D on 9/20/2017 due to a decline in the total return index, growth index and solvency index. EBIT declined 98.62% from -$1.35M to -$2.68M, the quick ratio declined from 12.91 to 5.48, and total revenue declined 52.42% from $1.29M to $615.9.
D
Sell
7/5/2017Upgraded
Prima Biomed Ltd. (PRRUF) was upgraded to D from D- on 7/5/2017 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 117.07% from $596.3 to $1.29M, and EBIT increased 12.14% from -$1.54M to -$1.35M.
Prima Biomed Ltd. (PRRUF) was upgraded to D from D- on 7/5/2017 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 117.07% from $596.3 to $1.29M, and EBIT increased 12.14% from -$1.54M to -$1.35M.
D
Sell
2/24/2017Upgraded
Prima Biomed Ltd. (PRRUF) was upgraded to D- from E+ on 2/24/2017 due to a noticeable increase in the growth index and efficiency index. Operating cash flow increased 1.18% from -$1.56M to -$1.54M, EBIT increased 1.18% from -$1.53M to -$1.51M, and net income increased 1.18% from -$1.54M to -$1.52M.
Prima Biomed Ltd. (PRRUF) was upgraded to D- from E+ on 2/24/2017 due to a noticeable increase in the growth index and efficiency index. Operating cash flow increased 1.18% from -$1.56M to -$1.54M, EBIT increased 1.18% from -$1.53M to -$1.51M, and net income increased 1.18% from -$1.54M to -$1.52M.
E
Sell
1/26/2017Downgrade
Prima Biomed Ltd. (PRRUF) was downgraded to E+ from D- on 1/26/2017 due to a substantial decline in the total return index, volatility index and valuation index.
Prima Biomed Ltd. (PRRUF) was downgraded to E+ from D- on 1/26/2017 due to a substantial decline in the total return index, volatility index and valuation index.
D
Sell
11/15/2016Upgraded
Prima Biomed Ltd. (PRRUF) was upgraded to D- from E on 11/15/2016 due to an increase in the growth index and efficiency index. Total revenue increased 3.27% from $180.7 to $186.6.
Prima Biomed Ltd. (PRRUF) was upgraded to D- from E on 11/15/2016 due to an increase in the growth index and efficiency index. Total revenue increased 3.27% from $180.7 to $186.6.
E
Sell
6/1/2016Downgrade
Immutep Limited (PRRUF) was downgraded to E from D on 06/01/2016.
Immutep Limited (PRRUF) was downgraded to E from D on 06/01/2016.
D
Sell
5/26/2016Upgraded
Prima Biomed Ltd. (PRRUF) was upgraded to D from D- on 5/26/2016 due to a noticeable increase in the volatility index and total return index.
Prima Biomed Ltd. (PRRUF) was upgraded to D from D- on 5/26/2016 due to a noticeable increase in the volatility index and total return index.
D
Sell
3/11/2016Downgrade
Prima Biomed Ltd. (PRRUF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the growth index, volatility index and solvency index. Total revenue declined 0.76% from $458.8 to $455.3.
Prima Biomed Ltd. (PRRUF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the growth index, volatility index and solvency index. Total revenue declined 0.76% from $458.8 to $455.3.
D
Sell
6/17/2014Upgraded
Prima Biomed Ltd. (PRRUF) was upgraded to D from E on 6/17/2014 due to an increase in the total return index.
Prima Biomed Ltd. (PRRUF) was upgraded to D from E on 6/17/2014 due to an increase in the total return index.
E
Sell
3/3/2014Downgrade
Prima Biomed Ltd. (PRRUF) was downgraded to E from D on 3/3/2014 due to a major decline in stability, total return and solvency.
Prima Biomed Ltd. (PRRUF) was downgraded to E from D on 3/3/2014 due to a major decline in stability, total return and solvency.
OTC PK
02/18/2025 9:30AM Eastern
Quotes delayed
